herefore reasoned that modulation of XBP-1s levels in cells should alter insulin action via its potential impact on the magnitude of the ER stress responses.
Hence, overexpression of XBP-1s rendered wild-type cells refractory to ER stress
Next, we examined whether these differences in the ER stress responses produced alterations in insulin action as assessed by IRS-1 serine phosphorylation and insulin-stimulated IRS-1 tyrosine phosphorylation
Hence, loss of an XBP-1 allele predisposes mice to diet-induced peripheral insulin resistance and type 2 diabetes.
Our experiments with cultured cells demonstrated an increase in ER stress and a decrease in insulin signaling capacity in XBP-1–deficient cells, as well as reversal of these phenotypes on expression of high levels of XBP-1s.
examined PERK phosphorylation and JNK activity in the livers
ncrease in PERK level
increase in liver PERK phosphorylation
increase in JNK activity
er307 phosphorylation of IRS-1 was also increased
IRS-1, and IRS-2 tyrosine- and Akt serine-phosphorylation, were all decreased in XBP-1+/–
in the adipose tissues of XBP-1+/–
Hence, our data demonstrate the link between ER stress and insulin action in vivo but are not conclusive in determining the exact locus in insulin receptor signaling pathway that is targeted through this mechanism.
down-regulation of XBP-1 leads to suppression of insulin receptor signaling in intact cells via IRE-1α–dependent activation of JNK
Deletion of an XBP-1 allele in mice leads to enhanced ER stress, hyperactivation of JNK, reduced insulin receptor signaling, systemic insulin resistance, and type 2 diabetes.
We therefore postulate that ER stress underlies the emergence of the stress and inflammatory responses in obesity and the integrated deterioration of systemic glucose homeostasis.
a role for ER stress in peripheral insulin resistance, earlier studies have linked ER stress with islet function and survival
Therefore, we propose that the effect of chronic ER stress on glucose homeostasis in obesity could represent a central and integrating mechanism underlying both peripheral insulin resistance and impaired insulin secretion.